Over the past 12 months, 11 insiders at Avidity Biosciences, Inc. filed 48 open-market SEC Form 4 transactions on RNA: 0 purchases worth $0 and 48 sales worth $31.9M. Insiders have been net sellers over this period. The most recent filing was on Jan 21, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 21, 26 | Sarah BoycePresident and CEO | SELL | 8.0K | $72.45 | $579K |
| Jan 21, 26 | W. Michael FlanaganChief Scientific Officer | SELL | 4.0K | $72.45 | $288K |
| Jan 21, 26 | Steven George HughesChief Medical Officer | SELL | 2.9K | $72.45 | $209K |
| Jan 21, 26 | Arthur A LevinDirector | SELL | 1.8K | $72.45 | $127K |
| Jan 21, 26 | Michael F MacleanChief Financial Officer | SELL | 2.7K | $72.45 | $198K |
| Jan 21, 26 | Teresa McCarthyChief Human Resources Officer | SELL | 1.5K | $72.45 | $107K |
| Jan 7, 26 | Sarah BoycePresident and CEO | SELL | 8.6K | $72.23 | $619K |
| Jan 7, 26 | Charles Calderaro IIIChief Technical Officer | SELL | 3.7K | $72.23 | $269K |
| Jan 7, 26 | W. Michael FlanaganChief Scientific Officer | SELL | 2.4K | $72.23 | $171K |
| Jan 7, 26 | Steven George HughesChief Medical Officer | SELL | 2.4K | $72.23 | $171K |
| Jan 7, 26 | Michael F MacleanChief Financial Officer | SELL | 2.0K | $72.23 | $143K |
| Jan 7, 26 | Teresa McCarthyChief Human Resources Officer | SELL | 2.0K | $72.23 | $142K |
| Jan 7, 26 | John B MoriartyChief Legal Officer | SELL | 2.4K | $72.23 | $171K |
| Oct 22, 25 | Steven George HughesChief Medical Officer | SELL | 2.2K | $47.54 | $105K |
| Oct 15, 25 | Teresa McCarthyChief Human Resources Officer | SELL | 20.0K | $50.15 | $1.0M |
| Oct 3, 25 | Eric MosbrookerChief Commercial Officer | SELL | 6.6K | $45.38 | $298K |
| Sep 22, 25 | Steven George HughesChief Medical Officer | SELL | 2.2K | $40.58 | $90K |
| Sep 15, 25 | Steven George HughesChief Medical Officer | SELL | 1.5K | $45.41 | $70K |
| Sep 15, 25 | Teresa McCarthyChief Human Resources Officer | SELL | 15.0K | $41.41 | $621K |
| Sep 11, 25 | W. Michael FlanaganChief Scientific Officer | SELL | 20.0K | $38.94 | $779K |
| Sep 5, 25 | Sarah BoycePresident and CEO | SELL | 50.0K | $49.95 | $2.5M |
| Sep 5, 25 | Troy Edward WilsonDirector | SELL | 15.0K | $50.00 | $750K |
| Sep 3, 25 | Eric MosbrookerChief Commercial Officer | SELL | 6.6K | $47.07 | $309K |
| Sep 2, 25 | Kathleen P. GallagherChief Program Officer | SELL | 188 | $47.42 | $9K |
| Aug 28, 25 | Sarah BoycePresident and CEO | SELL | 25.0K | $49.39 | $1.2M |
| Aug 22, 25 | Steven George HughesChief Medical Officer | SELL | 2.2K | $46.40 | $102K |
| Aug 15, 25 | Teresa McCarthyChief Human Resources Officer | SELL | 10.0K | $46.56 | $466K |
| Aug 13, 25 | Steven George HughesChief Medical Officer | SELL | 1.5K | $46.66 | $72K |
| Aug 6, 25 | Steven George HughesChief Medical Officer | SELL | 34.0K | $42.74 | $1.5M |
| Aug 6, 25 | Arthur A LevinDirector | SELL | 107.5K | $47.62 | $5.1M |
| Aug 6, 25 | Michael F MacleanChief Financial Officer | SELL | 30.9K | $42.73 | $1.3M |
| Aug 6, 25 | Eric MosbrookerChief Commercial Officer | SELL | 124.7K | $44.06 | $5.5M |
| Aug 6, 25 | Troy Edward WilsonDirector | SELL | 22.0K | $45.00 | $990K |
| Aug 4, 25 | John B MoriartyChief Legal Officer | SELL | 2.2K | $36.21 | $81K |
| Jun 17, 25 | Kathleen P. GallagherChief Program Officer | SELL | 911 | $30.24 | $28K |
| Jun 11, 25 | W. Michael FlanaganChief Scientific Officer | SELL | 20.0K | $32.88 | $658K |
| Jun 2, 25 | Kathleen P. GallagherChief Program Officer | SELL | 5.9K | $32.48 | $191K |
| May 1, 25 | Kathleen P. GallagherChief Program Officer | SELL | 5.9K | $32.40 | $190K |
| Apr 1, 25 | Kathleen P. GallagherChief Program Officer | SELL | 5.5K | $27.83 | $154K |
| Mar 20, 25 | Sarah BoycePresident and CEO | SELL | 31.5K | $31.06 | $980K |
| Mar 20, 25 | W. Michael FlanaganChief Scientific Officer | SELL | 11.8K | $31.06 | $366K |
| Mar 20, 25 | Steven George HughesChief Medical Officer | SELL | 9.6K | $31.06 | $297K |
| Mar 20, 25 | Michael F MacleanChief Financial Officer | SELL | 7.9K | $31.06 | $246K |
| Mar 20, 25 | Teresa McCarthyChief Human Resources Officer | SELL | 7.8K | $31.06 | $242K |
| Mar 11, 25 | W. Michael FlanaganChief Scientific Officer | SELL | 20.0K | $30.13 | $603K |
| Mar 3, 25 | Kathleen P. GallagherChief Program Officer | SELL | 5.9K | $29.41 | $173K |
| Feb 3, 25 | Kathleen P. GallagherChief Program Officer | SELL | 5.9K | $32.16 | $189K |
| Jan 22, 25 | Kathleen P. GallagherChief Program Officer | SELL | 5.6K | $30.16 | $170K |
| Jan 21, 25 | Sarah BoycePresident and CEO | SELL | 5.7K | $28.59 | $162K |
| Jan 21, 25 | W. Michael FlanaganChief Scientific Officer | SELL | 3.9K | $28.60 | $110K |
Over the past 12 months, insiders at Avidity Biosciences, Inc. filed 0 open-market purchases worth $0 and 48 sales worth $31.9M on RNA, which makes them net sellers over the period. The most recent Form 4 was filed on Jan 21, 26.
11 different insiders at Avidity Biosciences, Inc. filed open-market SEC Form 4 transactions on RNA over the last 12 months.
InsiderTape plots every RNA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Avidity Biosciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →